EVIVE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

EVIVE Trademark

Serial Number: 79295058 • Registration: 6488611

EVIVE is a trademark filed by EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD. on July 8, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

EVIVE BIOTECHNOLOGY SINGAPORE PTE. LTD. (4 trademarks)

150 BEACH ROAD, #32-05/08 GATEWAY WEST

Entity Type: 99

SCIGEN PTE. LTD. (4 trademarks)

150 Beach Road

Entity Type: 24

Trademark Details

Filing Date

July 8, 2020

Registration Date

September 21, 2021

Published for Opposition

July 6, 2021

Goods & Services

Pharmaceuticals, medical and veterinary preparations, namely, preparations for the treatment of infectious disease and for use in oncology, diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans, pharmaceutical preparations for use in chemotherapy, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for the treatment of viral infections and diseases, and antibacterial pharmaceuticals; pharmaceutical preparations for health care, namely, anti-inflammatory preparations, antipyretic preparations, biological preparations for the treatment of cancer, mixed biological preparations for the treatment and prevention of infectious diseases

Apparatus for medical use, namely, insulin pumps, insulin injectors sold empty, medical fluid injectors

Research and development services relating to medicines; medical laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design of medical apparatus for others; biotechnology research; research relating to pharmaceuticals

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 18, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Mar 7, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 7, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 21, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 21, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Jul 19, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 6, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 30, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 30, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 16, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2021 TROA
ATTORNEY REVIEW COMPLETED
Mar 25, 2021 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Mar 25, 2021 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 20, 2021 CRCV
CHANGE OF OWNER RECEIVED FROM IB
Mar 5, 2021 CHLD
REFUSAL PROCESSED BY IB
Dec 6, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 11, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 11, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 21, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 20, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 19, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 17, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 8, 2020 REPR